lifestyle.thedishh.com

Author: Helus Pharma

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

March 5, 2026
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

February 24, 2026
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

February 18, 2026
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

February 13, 2026
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

February 10, 2026